BioNeutra Global Corporation
BioNeutra Global Corporation (BGACF) Revenue
Annual & quarterly revenue history · segment & region breakdown
BGACF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsBioNeutra Global Corporation trailing twelve-month (TTM) revenue is $0.01B, a decrease of 15.00% year-over-year from $0.01B in FY2023.
Revenue trend
2023 – 2004 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-12-31 | $0.01B | -$0.00B | -15.00% |
| 2022-12-31 | $0.01B | -$0.00B | -13.05% |
| 2021-12-31 | $0.02B | -$0.01B | -36.14% |
| 2020-12-31 | $0.02B | -$0.01B | -36.03% |
| 2019-12-31 | $0.04B | -$0.00B | -0.04% |
| 2018-12-31 | $0.04B | +$0.01B | +17.34% |
| 2017-12-31 | $0.03B | +$0.01B | +23.67% |
| 2016-12-31 | $0.03B | +$0.01B | +61.99% |
| 2015-12-31 | $0.02B | +$0.00B | +2.38% |
| 2014-12-31 | $0.02B | +$0.01B | +106.84% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income BioNeutra Global Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
BioNeutra Global Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from BioNeutra Global Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BGACF revenue · 4 questionsBGACF's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 15.00% year-over-year from $0.01B in FY2023.
▸ Source: FMP · BioNeutra Global Corporation SEC filings · GAAP · BioNeutra Global Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026